SMS Pharmaceuticals Share

SMS Pharmaceuticals Gains After USFDA Approval of Reformulated Ranitidine Tablets | Q2 Numbers Show Strong Growth

The mood around SMS Pharmaceuticals shifted quickly this week. A familiar drug—once at the centre of global safety conversations—made its way back to the US market. And this return came with a direct connection to SMS Pharma’s partner, VKT Pharma, earning USFDA approval for its reformulated Ranit...

SMS Pharmaceuticals Share Price Jumps as USFDA Approves Reformulated Ranitidine Tablets

The SMS Pharmaceuticals share price had a sharp move today after a crucial regulatory update stirred fresh excitement in the market. The stock saw a strong rally as investors reacted to the approval of the company’s reformulated Ranitidine tablets, bringing back a medicine that has been missing f...